Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
BACKGROUND Regulatory guidance specifies the need to establish cardiovascular safety of new diabetes therapies in patients with type 2 diabetes in order to rule out excess cardiovascular risk.
S. Marso+14 more
semanticscholar +1 more source
Weight loss in type 2 diabetes [PDF]
Support from nurses is crucial to help obese and overweight patients achieve and maintain weight loss, explains Nicky ...
Kime, NH
core +1 more source
Ketoacidosis in type 2 diabetes- is it type 1 and ½ diabetes? [PDF]
A 64-year-old female with a background of type 2 diabetes became acutely unwell after being transferred from insulin to liraglutide, which is one of the new glucagon like peptide 1 analogues. On assessment in accident and emergency, she was diagnosed with diabetic ketoacidosis and pancreatits. Glutamic acid decarboxylase antibodies were positive at 45 (
Sathis Kumar+2 more
openaire +2 more sources
Insulin resistance in type 1 diabetes: what is ‘double diabetes’ and what are the risks? [PDF]
In this review, we explore the concept of ‘double diabetes’, a combination of type 1 diabetes with features of insulin resistance and type 2 diabetes.
A Caixas+62 more
core +3 more sources
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
BACKGROUND The effects of empagliflozin, an inhibitor of sodium-glucose cotransporter 2, in addition to standard care, on cardiovascular morbidity and mortality in patients with type 2 diabetes at high cardiovascular risk are not known.
B. Zinman+11 more
semanticscholar +1 more source
Interventions for prevention of type 2 diabetes in relatives:A systematic review [PDF]
The relatives and partners of people with type 2 diabetes are at increased risk of developing type 2 diabetes. This systematic review examines randomized controlled trials, written in English that tested an intervention, which aimed to modify behaviors ...
Dimova, Elena Dimcheva+3 more
core +4 more sources
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
BACKGROUND Type 2 diabetes affects approximately 8 percent of adults in the United States. Some risk factors--elevated plasma glucose concentrations in the fasting state and after an oral glucose load, overweight, and a sedentary lifestyle--are ...
W. Knowler+6 more
semanticscholar +1 more source
Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction. [PDF]
OBJECTIVES: To examine the prospective associations between consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice with type 2 diabetes before and after adjustment for adiposity, and to estimate the population ...
Bhupathiraju, Shilpa N+6 more
core +8 more sources
Ethnic differences in adiposity and diabetes risk – insights from genetic studies [PDF]
Type 2 diabetes is more common in non-Europeans and starts at a younger age and at lower BMI cut-offs. This review discusses the insights from genetic studies about pathophysiological mechanisms which determine risk of disease with a focus on the role of
Bell, J.D.+7 more
core +2 more sources
BACKGROUND Type 2 diabetes mellitus is increasingly common, primarily because of increases in the prevalence of a sedentary lifestyle and obesity. Whether type 2 diabetes can be prevented by interventions that affect the lifestyles of subjects at high ...
J. Tuomilehto+18 more
semanticscholar +1 more source